The Growing Popularity of Minor Cannabinoids: CBG, CBN, THCV, and More

Beyond THC and CBD lie a family of minor cannabinoids that are beginning to appear in specialised products and full-spectrum extracts. Research is still early for most of them, but consumer interest is rising as extraction and breeding make higher concentrations available.

CBG (cannabigerol)

Often called the “mother” cannabinoid because other cannabinoids derive from cannabigerolic acid. CBG is non-intoxicating. Early interest focuses on potential supporting roles in comfort and clarity. Some full-spectrum products now highlight elevated CBG.

CBN (cannabinol)

Forms as THC degrades, especially with time and heat. It is mildly psychoactive at most. Many people associate CBN with heavier, more sedating evening effects, which is why it appears in some sleep-oriented formulas. Evidence is still developing.

THCV (tetrahydrocannabivarin)

Structurally related to THC but with different receptor behaviour. At lower doses it is often described as clear or even slightly stimulating; at higher doses it can become more conventional. Some African landrace genetics are naturally higher in THCV.

CBC, CBDV and others

Cannabichromene (CBC) and cannabidivarin (CBDV) appear in smaller amounts in most cultivars. Research into their individual contributions is ongoing. In full-spectrum products they form part of the broader ensemble rather than starring on their own.

How to approach minor cannabinoids

Treat them as interesting variables rather than miracle ingredients. Full-spectrum flower and extracts already contain them in natural ratios. Isolated or enriched products allow more deliberate experimentation, but start low and track your own response.

Final perspective

The plant’s chemistry is richer than the two-letter compounds that dominate marketing. Paying attention to minor cannabinoids is one more way to move from generic consumption toward more intentional, informed use.